PROMO.ST
Price:
$0.11
Market Cap:
$293.55M
Promore Pharma AB (publ), a biopharmaceutical company, develops peptide-based drug candidates in Sweden and internationally. Its product candidates include PXL01 that is in Phase IIa study for the prevention of post-surgical adhesions and scars, and for the prevention of dermal scars, as well as for tendon repair surgery in the hand; and LL-37, which is in Phase IIb clinical studies for treating patients with venous leg ulcers, stimulate the healing of chronic wounds, and for the treatment of diabetic foot ulcers. It entered into a cooperation agreement with Fidia Farmaceutici S.p.A. for the production of hyaluronic acid syringes. The company was formerly known as Lipopeptide AB and changed ...[Read more]
Industry
Biotechnology
IPO Date
2017-07-06
Stock Exchange
STO
Ticker
PROMO.ST
According to Promore Pharma AB (publ)’s latest financial reports and current stock price. The company's current PE Ratio is -0.31. This represents a change of -99.83% compared to the average of -184.28 of the last 4 quarters.
The mean historical PE Ratio of Promore Pharma AB (publ) over the last ten years is 4.35K. The current -0.31 PE Ratio has changed -100.72% with respect to the historical average. Over the past ten years (40 quarters), PROMO.ST's PE Ratio was at its highest in in the June 2016 quarter at 12.82K. The PE Ratio was at its lowest in in the September 2016 quarter at -2810.86.
Average
4.35K
Median
-380.91
Minimum
-3684.73
Maximum
43.51K
Discovering the peaks and valleys of Promore Pharma AB (publ) PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 35.81%
Maximum Annual PE Ratio = 43.51K
Minimum Annual Increase = -106.24%
Minimum Annual PE Ratio = -3684.73
| Year | PE Ratio | Change |
|---|---|---|
| 2022 | -234.72 | -33.97% |
| 2021 | -355.48 | -12.24% |
| 2020 | -405.06 | 13.54% |
| 2019 | -356.75 | -62.03% |
| 2018 | -939.54 | -74.50% |
| 2017 | -3684.73 | 35.81% |
| 2016 | -2713.22 | -106.24% |
The current PE Ratio of Promore Pharma AB (publ) (PROMO.ST) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-331.76
5-year avg
-458.31
10-year avg
4.35K
Promore Pharma AB (publ)’s PE Ratio is greater than Medivir AB (publ) (-4.51), greater than ISR Immune System Regulation Holding AB (publ) (-1.23), less than Idogen AB (publ) (-0.16), less than Asarina Pharma AB (publ) (-0.05), greater than Pharmiva AB (publ) (-0.41), greater than Kancera AB (publ) (-0.90), less than Ziccum AB (publ) (-0.29), less than Cyxone AB (publ) (-0.08), less than Medhelp Care Aktiebolag (publ) (33.20), less than Scandion Oncology A/S (-0.02),
| Company | PE Ratio | Market cap |
|---|---|---|
| -4.51 | $402.33M | |
| -1.23 | $96.61M | |
| -0.16 | $12.79M | |
| -0.05 | $633.96K | |
| -0.41 | $12.93M | |
| -0.90 | $36.05M | |
| -0.29 | $8.56M | |
| -0.08 | $6.75M | |
| 33.20 | $210.00M | |
| -0.02 | $962.52K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Promore Pharma AB (publ) using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Promore Pharma AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Promore Pharma AB (publ)'s PE Ratio?
How is the PE Ratio calculated for Promore Pharma AB (publ) (PROMO.ST)?
What is the highest PE Ratio for Promore Pharma AB (publ) (PROMO.ST)?
What is the 3-year average PE Ratio for Promore Pharma AB (publ) (PROMO.ST)?
What is the 5-year average PE Ratio for Promore Pharma AB (publ) (PROMO.ST)?
How does the current PE Ratio for Promore Pharma AB (publ) (PROMO.ST) compare to its historical average?